Latest filing published 02 Sept 2021 for AbCellera Biologics Inc., €2.3M.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
John Hamer: trading record in brief
John Hamer, listed as board member, appears in our data through filings on AbCellera Biologics Inc. shares, published by SEC (Form 4). Over a trading history stretching from 15 December 2020 to 1 September 2021, the count stands at 6 filings.
The open-market record consists of 2 sales worth €4.3M, with no purchase. 2021 to date brings no purchases and 2 sales.
Most recently, on 2 September 2021, the filings show an open-market sale worth €2.0M in AbCellera Biologics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Hamer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 162,649 shares@ US$16.95100.0% of flowCommon SharesSEC:0001209191-21-054543:0
- 5,000,000 shares0Common SharesSEC:0000899243-21-025357:0
2 of 2 declarations
